A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

10.2K views

⸱

DOI:

10.3791/59050

⸱

March 8th, 2019

 ,  ,  ,  ,  ,  ,  , 

In This Article

Summary

The rodent left pneumonectomy is a valuable technique in pulmonary hypertension research. Here, we present a protocol to describe the rat pneumonectomy procedure and postoperative care to ensure minimal morbidity and mortality.

Abstract

In this protocol, we detail the correct procedural steps and necessary precautions to successfully perform a left pneumonectomy and induce PAH in rats with the additional administration of monocrotaline (MCT) or SU5416 (Sugen). We also compare these two models to other PAH models commonly used in research. In the last few years, the focus of animal PAH models has moved towards studying the mechanism of angioproliferation of plexiform lesions, in which the role of increased pulmonary blood flow is considered as an important trigger in the development of severe pulmonary vascular remodeling. One of the most promising rodent models of increased pulmonary flow is the unilateral left pneumonectomy combined with a "second hit" of MCT or Sugen. The removal of the left lung leads to increased and turbulent pulmonary blood flow and vascular remodeling. Currently, there is no detailed procedure of the pneumonectomy surgery in rats. This article details a step-by-step protocol of the pneumonectomy surgical procedure and post-operative care in male Sprague-Dawley rats. Briefly, the animal is anesthetized and the chest is opened. Once the left pulmonary artery, pulmonary vein, and bronchus are visualized, they are ligated and the left lung is removed. The chest then closed and the animal recovered. Blood is forced to circulate only on the right lung. This increased vascular pressure leads to a progressive remodeling and occlusion of small pulmonary arteries. The second hit of MCT or Sugen is used one week post-surgery to induce endothelial dysfunction. The combination of increased blood flow in the lung and endothelial dysfunction produces severe PAH. The primary limitation of this procedure is that it requires general surgical skills.

Introduction

Pulmonary arterial hypertension (PAH) is a progressive and fatal disease characterized by an increase in pulmonary blood flow, increased vascular resistance, inflammation, and remodeling of small pulmonary blood vessels1. This remodeling usually results in vascular lesions that obstruct and obliterate small pulmonary arteries, causing vasoconstriction and increasing right ventricle afterload2. Few successful pharmacological treatments of PAH exist; as a consequence, PAH-related mortality remains high. Recently, the focus of research on the pathobiology of pulmonary hypertension has moved towards a mechan....

Access restricted. Please log in or start a trial to view this content.

Protocol

The procedures described below have been approved by the Institutional Animal Care and Use Committee (IACUC) of the Icahn School of Medicine at Mount Sinai. All rats received humane care in compliance with the Mount Sinai “Guide for the Care and Use of Laboratory Animals”.

1. Preparation for Surgery

  1. Autoclave Cooley-Mayo curved scissors (large scissors), straight Iris scissors (small scissors), McPherson-Vannas Iris scissors (back scissors), Wangensteen tissue forceps (atraumatic forceps), Gerald tissue forceps, plain wire speculum (self-retaining retractor), small vessel cauterizer, gauze, double-ended probe, thin v....

Access restricted. Please log in or start a trial to view this content.

Results

According to the accepted classification system, pulmonary hypertension is characterized by a mean pulmonary artery pressure (mPAP) exceeding the upper limits of normal pulmonary artery pressure (i.e., 25 mm Hg). In the pneumonectomy + MCT group, severe PAH developed by day 21 with an increased mPAP (Figure 1). The mPAP is calculated by the formula:

Access restricted. Please log in or start a trial to view this content.

Discussion

In PAH-affected lungs, vascular proliferation with neointimal formation and obliteration of the pulmonary arteries result in severe hemodynamic changes, right ventricular failure and early mortality7,8. The changes to the vessel walls increase resistance to blood flow, increasing arterial and right ventricular pressure. In the early stages of PAH, usually 3 weeks after administering MCT or Sugen, rats developed nonspecific histological changes like medial hypertr.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have no potential conflicts of interest.

Acknowledgements

This manuscript was supported by NIH grant 7R01 HL083078-10 grants from the American Heart Association AHA-17SDG33370112 and from the National Institutes of Health NIH K01 HL135474 to Y.S. and from the National Institutes of Health R01 HL133554 to L.H.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Surgical BladeBard-Parker371215Incision
Forane (Isoflurane, USP)BaxterNDC 10019-360-40anesthesia
BD Angiocath 16 GBD381157intubation tube, chest tube
BD 1 mL Insulin SyringeBD329652administer buprinex post-operatively
Biogel Surgeons Surgical GlovesBiogel30460-01sterile surgical gloves
Wahl BravMini+ TrimmerBraintree ScientificCLP-41590 Pshave surgical site
SU5416Cayman Chemical13342Sugen 
Fiber Optic IlluminatorCole-ParmerEW-41723-02light for intubation
Surgipro II 4-0 SutureCovidienVP831XClosing intercostal muscles
Polysorb 5-0 SutureCovidienGL-885Closing skin
Medium Slide Top Induction ChamberDRE Veterinary12570oxygen & isoflurane delivery
DRE Compact 150 Rodent Anesthesia MachineDRE Veterinary373oxygen & isoflurane delivery
Small Vessel Cauterizer KitFine Science Tools18000-00cauterizer to minimize bleeding
VentElite Small Animal VentilatorHarvard Apparatus55-7040ventilator
MouseSTAT JrKent ScientificMSTAT-JRpulse oximeter & heart rate monitor
Mouse Paw Pulse Oximeter SensorKent ScientificSPO2-MSEpulse oximeter & heart rate paw sensor
PhysioSuite RightTempKent ScientificPS-02temperature pad
PVP Prep SolutionMedlineMDS093944Cleaning surgical site
Poly-lined DrapeMedlineNON21002Zcover animal
3 mL syringeMedlineSYR103010administer fluids post-operatively
Microsurgical Kits, Integra Miltex95042-540surgical tools: plain wire speculum, double-ended probe, McPherson-Vannas Iris scissors straight, straight iris scissors
Hemostatic forceps - Micro-Jacobson-MosquitoMiltex17-2602mosquito
Buprenorphrine HCl 0.3 mg/mLPar PharmaceuticalNDC 42023-179-01Pain relief
Cooley-Mayo curved scissorsPilling352090Large scissors
Gerald Tissue forcepsPilling351900forceps
Wangesnsteen Tissue ForcepsPilling342929atraumatic forceps
Pilling Thin Vascular Needle HolderPilling354962DGneedle holder
CrotalineSigma-AldrichC2401-1GMCT
Surflash 20 G IV CatheterTerumoSR*FF2051For pressure reading during organ harvest
ADVantage PV System with 1.2 Fr CatheterTransonic IncADV500Record pulmonary artery and right ventricle pressure
Medium HemoclipWeck523700ligate vessels
Open Ligating Clip Applicator; Medium, curvedWeck Horizon237081hemoclip applicator
Surgical MicroscopeZeiss OPMI MD1808magnification

References

  1. Leopold, J., Maron, B. Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension. International Journal of Molecular Sciences. 17 (5), 761(2016).
  2. Gomez-Arroyo, J. G., et al.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Monocrotaline ModelSugen ModelRat SurgeryPulmonary Artery PressureVascular RemodelingEndothelial DysfunctionPlexiform LesionsHematoxylin Eosin Staining